HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses.

Abstract
Donor lymphocyte infusion mediates most effective graft- versus-leukemia (GVL) effects following induction of host-versus-graft tolerance by transplantation of donor stem cells. This study was designed to maximize GVL effects across both major (MHC) and minor (mHgs) histocompatibility barriers in recipients inoculated with murine B-cell leukemia (BCL1), using specifically immune donor lymphocytes. GVL effects were induced with donor spleen cells from mice immunized across MHC or mHgs barriers with BCL/1 cells or normal BALB/c spleen cells. Our data suggest that spleen cells from donor mice immunized against murine B-cell leukemia of BALB/c origin, or to a lesser extent against normal host alloantigens, induce better therapeutic GVL effects with less great-versus-host disease (GVHD) across both mHgs and MHC. The cytokine profile of effector cells inducing predominantly GVL effects with reduced GVHD across MHC and mHg barriers consisted preferentially of upregulated IFN-gamma, IL-2, IL-10 and IL-12 in donors, implying a Th-1 to Th-2 cytokine shift. We hypothesize that immunotherapy with immune donor lymphocytes sensitized in vivo or in vitro with allogeneic tumor cells or normal host cells together with allogeneic BMT may provide an effective approach for amplifying GVL effects, while reducing procedure-related morbidity and mortality due to uncontrolled GVHD.
AuthorsY H Ji, L Weiss, M Zeira, A Abdul-Hai, S Reich, L Schuger, S Slavin
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 32 Issue 5 Pg. 495-504 (Sep 2003) ISSN: 0268-3369 [Print] England
PMID12942096 (Publication Type: Journal Article)
Chemical References
  • Cytokines
Topics
  • Animals
  • Cytokines (biosynthesis)
  • Graft vs Host Disease
  • Graft vs Leukemia Effect
  • Immunization (methods)
  • Immunotherapy, Adoptive (methods)
  • Leukemia, B-Cell (complications, mortality, therapy)
  • Lymphocyte Transfusion (methods)
  • Mice
  • Mice, Inbred Strains
  • Spleen (cytology, immunology, transplantation)
  • Transplantation Immunology
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: